CLBT
The table below shows Cellebrite DI Ltd.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Cash & equivalents | $179.22M | $106.96M | $110.50M | $91.69M |
| Short-term investments | $146.91M | $71.63M | $57.60M | $32.44M |
| Receivables | $93.13M | $125.00K | $112.00K | - |
| Inventory | $9.54M | $8.78M | $10.82M | $8.12M |
| Total current assets | $606.11M | $414.75M | $337.40M | $233.64M |
| Property, plant & equipment | $19.96M | $15.81M | $15.81M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $17.77M |
| Goodwill | $28.71M | $26.83M | $26.83M | $26.83M |
| Total assets | $787.42M | $556.58M | $425.89M | $324.84M |
| Accounts payable | - | - | - | - |
| Total current liabilities | $309.97M | $237.23M | $204.51M | $172.87M |
| Long-term debt | - | - | - | - |
| Total liabilities | $379.01M | $596.74M | $408.34M | $300.78M |
| Retained earnings | -$127.99M | $22.96M | $126.29M | $167.07M |
| Total equity | $408.41M | -$40.16M | $17.56M | $24.06M |